Alternative medicine on trial. Clinical trials home in on complementary therapies and complex natural products.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3512423)

Published in EMBO Rep on November 13, 2012

Authors

Philip Hunter

Articles by these authors

Xeno's paradox: why pig cells are better for tissue transplants than human cells. EMBO Rep (2009) 1.41

Not boring at all. Boron is the new carbon in the quest for novel drug candidates. EMBO Rep (2009) 0.98

Is political correctness damaging science? Peer pressure and mainstream thinking may discourage novelty and innovation. EMBO Rep (2005) 0.97

Fiat lux. Technical advances in biophotonics allow scientists to get a better picture of the cell. EMBO Rep (2007) 0.91

The impact of CO2. The global rise in the levels of CO2 is good for trees, bad for grasses and terrible for corals. EMBO Rep (2007) 0.91

The health of European medical research. Attempts are under way to update EU regulations, with the aim of harmonizing clinical research across the continent. EMBO Rep (2011) 0.89

The bigger picture. EMBO Rep (2005) 0.87

The human impact on biological diversity. How species adapt to urban challenges sheds light on evolution and provides clues about conservation. EMBO Rep (2007) 0.86

A toxic brew we cannot live without. Micronutrients give insights into the interplay between geochemistry and evolutionary biology. EMBO Rep (2008) 0.85

The paradox of model organisms. The use of model organisms in research will continue despite their shortcomings. EMBO Rep (2008) 0.85

Extended phenotype redux. How far can the reach of genes extend in manipulating the environment of an organism? EMBO Rep (2009) 0.84

All the evidence. EMBO Rep (2006) 0.84

Brain drain, brain gain or brain sharing? New studies of the migration routes of scientists show that international mobility benefits all parties including countries that are net exporters of researchers. EMBO Rep (2013) 0.82

The great leap forward. Major evolutionary jumps might be caused by changes in gene regulation rather than the emergence of new genes. EMBO Rep (2008) 0.82

Reading the metabolic fine print. The application of metabolomics to diagnostics, drug research and nutrition might be integral to improved health and personalized medicine. EMBO Rep (2009) 0.82

The silence of genes. Is genomic imprinting the software of evolution or just a battleground for gender conflict? EMBO Rep (2007) 0.82

Common defences. EMBO Rep (2005) 0.81

A late spring in Europe and the adaptability of plants. Epigenetic regulation seems to play a major role in plants' ability to adapt to and remember unusual climate patterns. EMBO Rep (2013) 0.81

The secret garden's gardeners. Research increasingly appreciates the crucial role of gut viruses for human health and disease. EMBO Rep (2013) 0.81

The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO Rep (2012) 0.80

Harnessing Nature's wisdom. Turning to Nature for inspiration and avoiding her follies. EMBO Rep (2008) 0.80

More is less. New developments in funding the life sciences to make research more effective. EMBO Rep (2007) 0.80

Biology is the new physics. EMBO Rep (2010) 0.79

Human intuition in the quantitative age. The role of mathematics in biology is vital, but does it leave room for 'old-fashioned' observation and interpretation? EMBO Rep (2011) 0.79

The psycho gene. EMBO Rep (2010) 0.78

Sepsis under siege: a new understanding of sepsis might lead to the development of therapies to treat septic shock. EMBO Rep (2006) 0.78

The nature of flight. The molecules and mechanics of flight in animals. EMBO Rep (2007) 0.77

The secret garden. The human digestive system is teeming with microbiotic life, but just how important are these interlopers for health and disease? EMBO Rep (2009) 0.77

The missing link. Viruses revise evolutionary theory. EMBO Rep (2010) 0.77

The return of the phage. EMBO Rep (2011) 0.77

Getting tough on pain. The potential of painkillers that take aim at chronic pain in smart new ways. EMBO Rep (2012) 0.77

The fourth front against cancer. The first clinical trials to test engineered viruses that attack tumour cells have yielded promising results for future cancer therapies. EMBO Rep (2011) 0.77

The mob response. The importance of biofilm research for combating chronic diseases and tackling contamination. EMBO Rep (2008) 0.76

A quantum leap in biology. One inscrutable field helps another, as quantum physics unravels consciousness. EMBO Rep (2006) 0.76

Into the fold. Advances in technology and algorithms facilitate great strides in protein structure prediction. EMBO Rep (2006) 0.76

Shedding a negative image. Research into their mechanism of infectivity reveals that prions might have important biological roles. EMBO Rep (2006) 0.76

The basis of morality. Psychologists, anthropologists and biologists are uncovering the bigger picture behind the development of empathy and altruism. EMBO Rep (2010) 0.76

Ancient rules of memory. The molecules and mechanisms of memory evolved long before their 'modern' use in the brain. EMBO Rep (2008) 0.76

To sleep, perchance to live. Sleeping is vital for health, cognitive function, memory and long life. EMBO Rep (2008) 0.76

H5N1 infects the biosecurity debate. Governments and life scientists are waking up to the problem of dual-use research. EMBO Rep (2012) 0.76

Anything you touch may be used against you. EMBO Rep (2010) 0.76

A question of faith. Exploiting the placebo effect depends on both the susceptibility of the patient to suggestion and the ability of the doctor to instill trust. EMBO Rep (2007) 0.76

The tide turns towards microalgae. Current research aims to produce traditional biofuels from algae, but their potential to generate sustainable energy might be even greater and more 'natural'. EMBO Rep (2010) 0.76

Research and practice coming together. The advent of personalized medicine is bringing clinical research and practice closer together. EMBO Rep (2012) 0.76

We are what we eat. The link between diet, evolution and non-genetic inheritance. EMBO Rep (2008) 0.76

Massing life. Research into biomass and food chains attracts increasing attention, given the biosphere's capacity to sequester CO2 from the atmosphere. EMBO Rep (2010) 0.75

Your decisions are what you eat. Metabolic state can have a serious impact on risk-taking and decision-making in humans and animals. EMBO Rep (2013) 0.75

Robust yet flexible. In biological systems, resistance to change and innovation in the light of it go hand in hand. EMBO Rep (2009) 0.75

New optics sheds light on biology. Advances in microscopy, genetics and biochemistry are together increasingly enabling scientists to watch molecules in action. EMBO Rep (2011) 0.75

Inevitable or avoidable? Despite the lessons of history, the world is not yet ready to face the next great plague. EMBO Rep (2007) 0.75

Wealth and health. Will the global credit crunch cause a health crunch in the most affected countries? EMBO Rep (2009) 0.75

Economic (un)natural selection. Could the credit crunch 'weed out' weaker research projects, institutes or even countries, improving research quality overall? EMBO Rep (2009) 0.75

The great regulator. Basic research into the roles of RNA is steaming ahead, but its commercial exploitation has stalled. EMBO Rep (2011) 0.75

EU-LIFE revives funding debate. A group of mid-level life science research institutes is reopening the debate on how to fund research at the EU level calling for a stronger emphasis on excellence. EMBO Rep (2013) 0.75

Laptop biology. As mathematics and computation increasingly invade laboratories, biologists need to master new skills. EMBO Rep (2005) 0.75

Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving. EMBO Rep (2010) 0.75

XNA marks the spot. What can we learn about the origins of life and the treatment of disease through artificial nucleic acids? EMBO Rep (2013) 0.75

Me, myself and I. The genetics and molecular biology behind self-incompatibility and the avoidance of inbreeding in plants. EMBO Rep (2009) 0.75

Can bacteria save the planet? EMBO Rep (2010) 0.75

The cost of living longer. Fertility trades with immunity and life expectancy. EMBO Rep (2011) 0.75

Defining species: the indirect impact of humans on biodiversity. EMBO Rep (2006) 0.75

The science of progress and the progress of science. With increasing demands for science to provide value, how do we assess research to ensure that short-term gains do not undermine long-term goals? EMBO Rep (2013) 0.75

To protect and save. A new chapter opens on biodiversity conservation. EMBO Rep (2011) 0.75

A new era for plant biotechnology. A combination of pharmaceutical applications, technologies and safety measures could lead to new applications for genetically modified plants. EMBO Rep (2011) 0.75

Natural solutions to climate change. Greenhouse gases, high-energy crops and the future of the world. EMBO Rep (2008) 0.75

Back down to Earth. Even if it has not yet lived up to its promises, systems biology has now matured and is about to deliver its first results. EMBO Rep (2012) 0.75

The cutting edge. A synergy of modern surgical techniques and science improves patient survival and recovery. EMBO Rep (2007) 0.75

Facing the credit crunch. Politics sends mixed messages for science in the wake of the global financial crisis. EMBO Rep (2010) 0.75

Not so simple after all. A renaissance of research into prokaryotic evolution and cell structure. EMBO Rep (2008) 0.75

Nutrition: more than the sum of its parts. The modern craze for dietary supplements is under increasing scrutiny, while biofortified crops look promising in the quest to deliver nutrition in developing countries. EMBO Rep (2011) 0.75

Science cannot be left to the market alone: Meshing basic research with fiscal competitiveness is the key to economic success. EMBO Rep (2006) 0.75

Viral vigilance. New surveillance strategies and methods help to identify dangerous pathogens earlier: a prerequisite for efficient countermeasures. EMBO Rep (2008) 0.75

Ancient DNA research goes nuclear. A new technique to extract sequence data from nuclear DNA may reveal exciting new insights into evolution and phylogeny. EMBO Rep (2006) 0.75

Undergraduate research. Winning the battle for students' hearts and minds. EMBO Rep (2007) 0.75

What doesn't kill you makes you dumber. Strengthening the link between infectious disease, intelligence and personality. EMBO Rep (2012) 0.75

Caught in the act. Femtochemistry opens the lid on biology's third vital criterion. EMBO Rep (2012) 0.75

Where next for antibiotics? The immune system and the nature of pathogenicity are providing vital clues in the fight against antibiotic-resistant bacteria. EMBO Rep (2012) 0.75

A word of advice. EMBO Rep (2005) 0.75

The changing hypothesis of the gut. The intestinal microbiome is increasingly seen as vital to human health. EMBO Rep (2012) 0.75

Dig this. Biomolecular archaeology provides new insights into past civilizations, cultures and practices. EMBO Rep (2007) 0.75

How smart is smart? Is human intelligence still evolving? EMBO Rep (2009) 0.75

All in the mind? New molecular insights might bridge the gap between the effects of psychiatric therapy and drugs. EMBO Rep (2009) 0.75

Molecular fossils probe life's origins. Research into molecular fossils and modern viruses is shedding light on the evolution of archaea, prokaryotes and eukaryotes. EMBO Rep (2013) 0.75

Is eternal youth scientifically plausible? Research on the role of free radicals in ageing gives cause for optimism. EMBO Rep (2007) 0.75

Total recall. Reconsolidation theory unifies cognitive psychology and neuroscience and creates new therapeutic options for memory-related disorders. EMBO Rep (2011) 0.75

Fight fire with fire. Can biopesticides fill the void left by banning chemical pesticides and herbicides? EMBO Rep (2009) 0.75

A new target for personalized medicine. EMBO Rep (2011) 0.75

I research, therefore I am? A purely scientific understanding of consciousness remains elusive, but the search for its neurological foundation continues. EMBO Rep (2010) 0.75

Entente cordiale: multiple symbiosis illustrates the intricate interconnectivity of nature. EMBO Rep (2006) 0.75

Hitting the right spot. EMBO Rep (2010) 0.75

The recruitment crunch. EMBO Rep (2008) 0.75

Academic labour shortages. A lack of trained scientists could slow down research in Europe. EMBO Rep (2012) 0.75

Research funding is not enough. Universities need more support for teaching and facility maintenance to stay fit for the future. EMBO Rep (2013) 0.75